Quadruple marker is a mandatory screening test done in the second trimester between 15 to 20 weeks of pregnancy. It is screened for four important hormones in pregnant women. They are alpha-fetoprotein, human chorionic gonadotropin, estriol, and inhibin A. It helps to diagnose the risk of developing Down syndrome, Edwards' syndrome, spina bifida, and anencephaly in babies.
Hi, Welcome to icliniq.com. It is done to screen for the possibility of certain birth defects in the baby, like Down's syndrome, abnormalities of the brain and spinal cord.
Hello, Welcome to icliniq.com. The risk as mentioned is high.
Hello, Welcome to icliniq.com. The NT value (nuchal translucency) is normal as it is less than 2.5 mm, but the overall trisomy 21 risks being 1:214 and together risk 1:513 .
Hello, Welcome to icliniq.com. From your reports (attachment removed to protect patient identity), the risk is relatively high for you. But, it does not mean that the baby has Down's syndrome.
Hi, Welcome to icliniq.com. I have gone through your question and understand your concerns. I have reviewed the quadruple marker report (attachment removed to protect patient identity).
Hi, Welcome to icliniq.com.First of all, I would like to congratulate you on starting this beautiful journey, being a mom of two, I understand your concerns. Here is what I would suggest.
Hi, Welcome to icliniq.com. From your history, I gather that you have been taking insulin from early pregnancy and closely following it.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.